Sarcopenia disease in Iran: an overview.
Iran
Research
Sarcopenia
Journal
Journal of diabetes and metabolic disorders
ISSN: 2251-6581
Titre abrégé: J Diabetes Metab Disord
Pays: Switzerland
ID NLM: 101590741
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
10
07
2019
accepted:
10
10
2019
entrez:
1
1
2020
pubmed:
1
1
2020
medline:
1
1
2020
Statut:
epublish
Résumé
Sarcopenia is a geriatric disease with adverse clinical outcomes, high rate of mortality and a major challenge to healthy elderly. This study aimed to undertake a survey to identify gaps and highlight strengths in sarcopenia research in order to progress research in this area for the next years in Iran. This study included all studies published from the beginning until the first of 2019 in national and international journals by Iranian authors conducted in the field of sarcopenia. The databases including MEDLINE (via PubMed), Web of Science and SCOPUS were used as the sources of information. All relevant available academic studies, including review articles, original articles, case reports, conference abstracts, and letters were included in the analysis. A total of 48 articles obtained and then categorized into six groups. These groups were; about Pathophysiology, Epidemiology of sarcopenia, Screening of sarcopenia, Nutrition, Physical activity and Association of Sarcopenia and Other Diseases that briefly findings of each study had been described. These findings showed that the prevalence of sarcopenia was 16.5% to 32.5%, using different definitions. A study developed and validated a screening model for identifying people with sarcopenia. Lifestyle changes such as diet can be appropriate strategies for the prevention of sarcopenia and also, physical activity is considered to be one of the few effective strategies to improve sarcopenia and prevent its outcomes, especially if in combination with appropriate nutritional supplementation. Sarcopenia is associated with adverse outcomes and other serious areas such as metabolic disorders, cancers, cardiovascular diseases, nephrology, gastroenterology, psychiatry, other geriatric diseases (such as osteoporosis, etc) and death. Some studies about these areas have been done in Iran. By this study, we found that studies on sarcopenia, the gaps of sarcopenia research in Iran, and highlighted the research priorities for future works. The outcome of the present research is to ultimately improve the health, quality of life and well-being of sarcopenic people.
Sections du résumé
BACKGROUND
BACKGROUND
Sarcopenia is a geriatric disease with adverse clinical outcomes, high rate of mortality and a major challenge to healthy elderly. This study aimed to undertake a survey to identify gaps and highlight strengths in sarcopenia research in order to progress research in this area for the next years in Iran.
METHODS
METHODS
This study included all studies published from the beginning until the first of 2019 in national and international journals by Iranian authors conducted in the field of sarcopenia. The databases including MEDLINE (via PubMed), Web of Science and SCOPUS were used as the sources of information. All relevant available academic studies, including review articles, original articles, case reports, conference abstracts, and letters were included in the analysis.
FINDINGS
RESULTS
A total of 48 articles obtained and then categorized into six groups. These groups were; about Pathophysiology, Epidemiology of sarcopenia, Screening of sarcopenia, Nutrition, Physical activity and Association of Sarcopenia and Other Diseases that briefly findings of each study had been described. These findings showed that the prevalence of sarcopenia was 16.5% to 32.5%, using different definitions. A study developed and validated a screening model for identifying people with sarcopenia. Lifestyle changes such as diet can be appropriate strategies for the prevention of sarcopenia and also, physical activity is considered to be one of the few effective strategies to improve sarcopenia and prevent its outcomes, especially if in combination with appropriate nutritional supplementation. Sarcopenia is associated with adverse outcomes and other serious areas such as metabolic disorders, cancers, cardiovascular diseases, nephrology, gastroenterology, psychiatry, other geriatric diseases (such as osteoporosis, etc) and death. Some studies about these areas have been done in Iran.
CONCLUSIONS
CONCLUSIONS
By this study, we found that studies on sarcopenia, the gaps of sarcopenia research in Iran, and highlighted the research priorities for future works. The outcome of the present research is to ultimately improve the health, quality of life and well-being of sarcopenic people.
Identifiants
pubmed: 31890691
doi: 10.1007/s40200-019-00452-9
pii: 452
pmc: PMC6915182
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
665-674Informations de copyright
© Springer Nature Switzerland AG 2019.
Déclaration de conflit d'intérêts
Conflict of interestThe authors declared that they have no conflict of interest.
Références
PeerJ. 2018 Sep 5;6:e5239
pubmed: 30202641
Life Sci. 2018 Jun 1;202:103-109
pubmed: 29604268
Nutrition. 2015 Jan;31(1):97-104
pubmed: 25441592
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
Trends Pharmacol Sci. 2018 Apr;39(4):331-353
pubmed: 29502887
Arch Gerontol Geriatr. 2016 Sep-Oct;66:18-22
pubmed: 27176487
J Am Med Dir Assoc. 2016 Aug 1;17(8):675-7
pubmed: 27470918
Biol Trace Elem Res. 2013 Jun;153(1-3):111-8
pubmed: 23619906
J Aging Phys Act. 2019 Jun 1;27(3):384-391
pubmed: 30299198
J Diabetes Metab Disord. 2017 May 16;16:21
pubmed: 28523252
Kidney Res Clin Pract. 2018 Dec;37(4):404-413
pubmed: 30619696
Geriatr Gerontol Int. 2018 Feb;18(2):197-210
pubmed: 28858409
Ann Surg Oncol. 2017 Dec;24(Suppl 3):628-629
pubmed: 29039028
Front Med (Lausanne). 2017 Oct 04;4:167
pubmed: 29046874
J Diabetes Metab Disord. 2012 Nov 21;11(1):23
pubmed: 23497567
J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):19-24
pubmed: 27897416
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):542-548
pubmed: 28251827
Crit Rev Food Sci Nutr. 2019;59(9):1456-1466
pubmed: 29266964
J Caring Sci. 2018 Sep 01;7(3):137-142
pubmed: 30283758
J Cachexia Sarcopenia Muscle. 2018 Dec;9(6):1023-1033
pubmed: 30311434
J Diabetes Metab Disord. 2014 Aug 21;13(1):88
pubmed: 25247153
J Am Med Dir Assoc. 2014 Feb;15(2):95-101
pubmed: 24461239
BMJ Open. 2017 Aug 04;7(8):e013606
pubmed: 28780537
Aging Clin Exp Res. 2017 Dec;29(6):1241-1248
pubmed: 28224473
J Am Med Dir Assoc. 2011 May;12(4):249-56
pubmed: 21527165
Med Hypotheses. 2015 Jul;85(1):1-6
pubmed: 25976755
Osteoporos Int. 2017 Jun;28(6):1817-1833
pubmed: 28251287
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):535-546
pubmed: 27104109
J Diabetes Metab Disord. 2017 Apr 20;16:19
pubmed: 28439503
Iran J Med Sci. 2017 Nov;42(6):569-576
pubmed: 29184265
Osteoporos Int. 2020 Oct;31(10):1975-1984
pubmed: 32440891
Ethiop J Health Sci. 2016 Jul;26(4):389-96
pubmed: 27587937
BMC Public Health. 2017 Jan 13;17(1):72
pubmed: 28086842
Iran J Kidney Dis. 2018 Jan;12(1):53-60
pubmed: 29421778
Int J Prev Med. 2018 Mar 09;9:25
pubmed: 29619149